Abbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Abbott Labs (ABT) PT Raised to $72 at Cowen
July 19, 2018 8:23 AM EDTCowen raised its price target on Abbott Labs (NYSE: ABT) to $72.00 (from $68.00) while maintaining a Outperform rating following solid Q2 results.
Analyst Joshua Jennings notes organic growth was 8%, versus 6%-7% guidance range and also north of the 7% organic rate shown in 1Q. Also, guidance was raised despite a strong dollar.
... MoreAbbott Labs (ABT) PT Raised to $70 at RBC Capital
July 19, 2018 7:16 AM EDTRBC Capital raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $67.00) while maintaining a Outperform rating.
Analyst Glenn Novarro said results again demonstrated powerful momentum across all four segments, especially outside the U.S.
... MoreAbbott Labs (ABT) PT Raised to $70 at Evercore ISI
July 18, 2018 12:19 PM EDTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $66.00) while maintaining a Outperform rating.
What analyst Vijay Kumar liked in the quarter:
8% organic topline came in above ST and whisper expectationsNutrition came in above (~2% above ST) and... More